213 related articles for article (PubMed ID: 16202216)
1. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
Malik RA; Li C; Aziz W; Olson JA; Vohra A; McHardy KC; Forrester JV; Boulton AJ; Wilson PB; Liu D; McLeod D; Kumar S
J Cell Mol Med; 2005; 9(3):692-7. PubMed ID: 16202216
[TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
3. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy.
Blum A; Socea D; Ben-Shushan RS; Keinan-Boker L; Naftali M; Segol G; Tamir S
Eur Cytokine Netw; 2012; 23(4):158-62. PubMed ID: 23328414
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
6. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy.
Marek N; Raczyńska K; Siebert J; Myśliwiec M; Zorena K; Myśliwska J; Reiwer-Gostomska M; Trzonkowski P
Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846
[TBL] [Abstract][Full Text] [Related]
7. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
[TBL] [Abstract][Full Text] [Related]
8. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Lecube A; Segura RM; Sararols L; Simó R
Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
12. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
Wu S; He X
Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
Ma Y; Zhang Y; Zhao T; Jiang YR
Am J Ophthalmol; 2012 Feb; 153(2):307-313.e2. PubMed ID: 21982107
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
Chen W; Lu Q; Lu L; Guan H
Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
16. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
17. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
18. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
20. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
